PRN: Influenza Vaccine Market in Italy, Malta, Portugal and Spain - Market Will Increase to US$ 209.1 Million by the Year 2022 - Research and Markets

02/mag/2017 13:00:19 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 6 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Influenza Vaccine Market in Italy, Malta, Portugal and Spain - Market Will Increase to US$ 209.1 Million by the Year 2022 - Research and Markets

 
[02-May-2017]
 

DUBLIN, May. 02, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Influenza Vaccine Market in Italy, Malta, Portugal and Spain (South Europe) By (Child & Adult) Forecast" report to their offering.

Research and Markets Logo

According to this report 'Influenza Vaccine Market in Italy, Malta, Portugal and Spain (South Europe) By (Child & Adult) Forecast', in the Southern European countries, Italy is having the highest seasonal influenza vaccine market share followed by Spain. In terms of children vaccination, Italy & Spain holds more than 80 percent market share whereas, in adult vaccination segments, these two will share more than 90 percent market share by 2022.

This report provides a complete analysis of 4 Southern European Countries (Italy, Malta, Portugal and Spain) Seasonal Influenza Vaccine Market (Child & Adult), Number of Vaccinated Population (Child & Adult) and Forecast till 2022.

Growth Drivers:

  • Vaccine Manufacturers Plan to Increase Flu Vaccine Production
  • Declining Child Population & Accelerating Ageing Population in Southern European Region
  • Rising Healthcare Expenditure Share of the Southern Europe Countries GDP

Challenges:

  • Regulatory Challenges with New and Novel Influenza Vaccines
  • Lack of Healthcare Infrastructure
  • Limited Reimbursement and Access to the Vaccines

Countries Covered

  • Italy
  • Malta
  • Portugal
  • Spain

Key Topics Covered:

1. Executive Summary

2. Southern European Countries Seasonal Influenza Vaccinated Total Population

3. Southern European Countries Seasonal Influenza Vaccine Market s

4. Southern Europe Countries Seasonal Influenza Vaccine Market Share

5. Italy

6. Malta

7. Portugal

8. Spain

9. Seasonal Influenza Vaccine - Growth Drivers

10. Seasonal Influenza Vaccine - Challenges

For more information about this report visit http://www.researchandmarkets.com/research/mfc7r4/influenza_vaccine

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl